p53 and DCC immunohistochemistry in curative rectal cancer surgery

International Journal of Colorectal Disease

Volumn 18, Issue 3, 2003, Pages 188-195

  Morgan, M ^a   Koorey, D ^b   Painter, D ^b   Findlay, M ^c   Newland, R ^d   Chapuis, P ^a   Solomon, M ^a,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c WELLINGTON HOSPITAL   (New Zealand)

^d ANZAC Research Institute   (Australia)

^e RPA Medical Centre   (Australia)

Author keywords

DCC; Immunohistochemistry; Local recurrence; p53; Rectal cancer; Survival

Indexed keywords

PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER INVASION; CANCER STAGING; CHROMOSOME 18Q; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 0038480144     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-002-0434-3     Document Type: Article

References (53)

1. Chapuis PH, Dent OF, Fisher R, et al (1985) Multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 72:698-702
2. Hermanek P, Guggenmoos-Holzmann I, Gall FP (1989) Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification. Dis Colon Rectum 32:593-599
3. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
4. Jen J, Kim H, Piantadosi S, et al (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331:213-221
5. Laurent-Puig P, Olschwang S, Delattre O, et al (1992) Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 102:1136-1141
6. Lane DP (1992) p53, guardian of the genome. Nature 358:15-16
7. Zeng ZS, Sarkis AS, Zhang ZF, et al (1994) p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol 12:2043-2050
8. Yamaguchi A, Nakagawara G, Kurosaka Y, Nishimura G, Yonemura Y, Miyazaki I (1993) p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. Br J Cancer 68:399-402
9. Yamaguchi A, Kurosaka Y, Fusida S, et al (1992) Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 70:2778-2784
10. Starzynska T, Bromley M, Ghosh A, Stern PL (1992) Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 66:558-562
11. Grewal H, Guillem JG, Klimstra DS, Cohen AM (1995) P53 nuclear overexpression may not be an independent prognostic marker in early colorectal cancer. Dis Colon Rectum 38:1176-1181
12. Dix BR, Robbins P, Soong R, Jenner D, House AK, Iacopetta BJ (1994) The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 59:747-751
13. Morrin M, Kelly M, Barrett N, Delaney P (1994) Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut 35:1627-1631
14. Subramaniam P, Sinha SN, Wilkinson S (1995) Immunohistochemical detection of p53 and the recurrence of rectal adenocarcinoma. Aust NZ J Surg 65:740-742
15. Fearon ER, Cho KR, Nigro JM, et al (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49-56
16. Cho KR, Oliner JD, Simmons JW, et al (1994) The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 19:525-531
17. Fazeli A, Dickinson SL, Hermiston ML, et al (1997) Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature 386:796-804
18. Chen YQ, Hsieh JT, Yao F, et al (1999) Induction of apoptosis and G2/M cell cycle arrest by DCC. Oncogene 18:2747-2754
19. Shibata D, Reale MA, Lavin P, et al (1996) The DCC protein and prognosis in colorectal cancer. N Engl J Med 335:1727-1732
20. Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F (1998) DCC protein as a predictor of distant metastases after curative surgery for rectal cancer. Dis Colon Rectum 41:755-760
21. Davis NC, Newland RC (1983) The reporting of colorectal cancer: the Australian Clinico-pathological Staging (ACPS) System. Med J Aust 1:282
22. Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B, Hamilton SR (1994) An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172:5-12
23. Taylor CR, Shi SR, Chaiwun B, Young L, Imam SA, Cote RJ (1994) Strategies for improving immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum Pathol 25:263-270
24. Hall PA, Lane DP (1994) p53 in tumour pathology: can we trust immunohistochemistry? Revisited! J Pathol 172:1-4
25. Sun XF, Carstensen JM, Zhang H, et al (1992) Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340:1369-1373
26. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP (1984) Local recurrence following 'curative' surgery for large bowel cancer. II. The rectum and rectosigmoid. Br J Surg 71:17-20
27. McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB (1985) Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg 72:34-37
28. Karanjia ND, Schache DJ, North WR, Heald RJ (1990) 'Close shave' in anterior resection. Br J Surg 77:510-512
29. Bokey EL, Chapuis PH, Dent OF, et al (1997) Factors affecting survival after excision of the rectum for cancer: a multivariate analysis. Dis Colon Rectum 40:3-10
30. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL (1994) Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 73:2076-2082
31. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC (1980) The clinical significance of invasion of veins by rectal cancer. Br J Surg 67:439-442
32. Jass JR, Atkin WS, Cuzick J, et al (1986) The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 10:437-459
33. Lanza G Jr, Maestri I, Dubini A, et al (1996) p53 expression in colorectal cancer: relation to tumour type, DNA ploidy pattern, and short-term survival. Am J Clin Pathol 105:604-612
34. Bell SM, Scott N, Cross D, et al (1993) Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 104:57-64
35. Auvinen A, Isola J, Visakorpi T, Koivula T, Virtanen S, Hakama M (1994) Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer 70:293-296
36. Prioleau J, Schnitt SJ (1995) p53 antigen loss in stored paraffin slides. N Engl J Med 332:1521-1522
37. McCall JL, Cox MR, Wattchow DA (1995) Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 10:126-132
38. Wiggenraad R, Tamminga R, Blok P, Rouse R, Hermans J (1998) The prognostic significance of p53 expression for survival and local control in rectal cancer treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 41:29-35
39. Liang JT, Cheng YM, Chang KJ, Chien CT, Hsu HC (1999) Reappraisal of K-ras and p53 mutations in the recurrence of Dukes' B2 rectal cancer after curative resection. Hepatogastroenterology 46:830-837
40. Adell G, Sun XF, Stal O, Klintenberg C, Sjodahl R, Nordenskjold B (1999) p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother Oncol 51:169-174
41. Luna-Perez P, Arriola EL, Cuadra Y, Alvarado I and Quintero A (1998) p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma. Ann Surg Oncology 5:203-208
42. Kerns BJ, Jordan PA, Moore MB, et al (1992) p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. J Histochem Cytochem 40:1047-1051
43. Goh HS, Yao J, Smith DR (1995) p53 point mutation and survival in colorectal cancer patients. Cancer Res 55:5217-5221
44. Hamelin R, Laurent-Puig P, Olschwang S, et al (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106:42-48
45. Goh HS, Chan CS, Khine K, Smith DR (1994) p53 and behaviour of colorectal cancer. Lancet 344:233-234
46. Pricolo VE, Finkelstein SD, Wu TT, et al (1996) Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg 171:41-46
47. Bosari S, Viale G, Roncalli M, et al (1995) p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol 147:790-798
48. Kern SE, Fearon ER, Tersmette KW, et al (1989) Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 261:3099-3103
49. O'Connell MJ, Schaid DJ, Ganju V, Cunningham J, Kovach JS, Thibodeau SN (1992) Current status of adjuvant chemotherapy for colorectal cancer. Can molecular markers play a role in predicting prognosis? Cancer 70:1732-1739
50. Iino H, Fukayama M, Maeda Y, et al (1994) Molecular genetics for clinical management of colorectal carcinoma. Cancer 73:1324-1331
51. Ookawa K, Sakamoto M, Hirohashi S, et al (1993) Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer 53:382-387
52. Saito M, Yamaguchi A, Goi T, et al (1999) Expression of DCC protein in colorectal tumours and its relationship to tumour progression and metastasis. Oncology 56:134-141
53. Nehls O, Klump B, Holzman K, Lammering G, Borchard F, Gruenagel HH, Gaco V, Gregor M, Porschen R (1999) Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma. Cancer 85:2541-2548